ECRON-ACUNOVA
4.12.2015 10:24:06 CET | Business Wire | Press release
Anders Malm, Managing Director of Ecron Acunova and responsible for operations in Europe and North America is pleased to announce that Erik Carp has joined Ecron Acunova as Leader Nordic Region.
Erik Carp joined Ecron Acunova in November with responsibility for the Nordic Region. He will bring much operational experience from local and multinational clinical trials within different therapeutic areas. With a Master in pharmacy from Copenhagen University and a Bachelor in business administration from Copenhagen Business School, Erik Carp brings about 25 years of international clinical operations and business experience from pharmaceutical and biotech companies to Ecron Acunova.
Ecron Acunova (www.ecronacunova.com ) is an expert CRO with over 25 years of track record covering 19 European countries, 9 Asian countries and the United States and Canada. It offers full service clinical research including clinical operations, data management, biostatistics, pharmacovigilance, medical writing, PK/PD services and central laboratory services to pharma, biotech, medical device, nutrition and diagnostic companies. Ecron Acunova operates each region as a priority market with European HQ in Frankfurt, Asian HQ in Singapore, and US HQ in Princeton. With a team of over 350 professionals including about 70 MDs and PhDs, Ecron Acunova is reputed to accelerate pharma time‐to‐market cost effectively.
Speaking on the appointment, Anders Malm, CEO Ecron Acunova Europe, said, “Mr. Carp brings extensive experience in clinical research and he has worked with several CROs over the years as a sponsor. With his experience, Erik Carp can contribute to ensuring that Ecron Acunova’s services continue to meet the specific needs of each our sponsors in terms of quality, timing and budgets. We will continue to serve existing clients and build close relations with biotech and pharmaceutical companies for global as well as local services”.
On his appointment, Mr. Carp said, “Ecron Acunova is a CRO with vast experience within many therapeutic areas. With a highly trained staff in three continents Ecron Acunova has a knowledge base which is unique for a CRO of our size. The company has a global reach, while at the same time we can take care of clients on a local and personal basis. The right size matters in this industry and Ecron Acunova can adapt to the size of each of the sponsors we serve. In our organization, each employee can contribute to the success of our sponsors, make a real difference every day, be visible, accountable and constantly strengthen and develop existing and new competencies. It is a pleasure and privilege for me to be part of Ecron Acunova”.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151204005233/en/
Contact:
Ecron Acunova Europe HQ
Anders Malm
anders.malm@ecronacunova.com
+49
69 6680 300
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Quantum Computers Becomes First European Quantum Computing Company Listed on a Major U.S. Exchange2.7.2026 16:47:00 CEST | Press release
IQM begins trading on Nasdaq Global Select Market under the ticker symbol “IQMX” Company enters next phase of growth as a publicly traded leader in full-stack superconducting quantum computing IQM maintains a strong pro forma cash position of EUR 337 million IQM Quantum Computers (Nasdaq: IQMX) (“IQM”, “IQM Quantum Computers” or the “Company”), a global leader in full-stack superconducting quantum computers, today became a publicly traded company following the completion of its business combination with Real Asset Acquisition Corp. (“RAAQ”). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260702960460/en/ IQM Quantum Computers Becomes First European Quantum Computing Company Listed on a Major U.S. Exchange The company’s American Depositary Shares begin trading today on the Nasdaq Global Select Market under the ticker symbol “IQMX”. The listing marks a major milestone for IQM establishing the company as the first European quan
GigaDevice Launches First GD24CL Series I²C EEPROM, Further Expanding Its Non-Volatile Memory Portfolio2.7.2026 16:00:00 CEST | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, announced today the launch of its new GD24CL series I²C EEPROM. The series delivers outstanding performance, comprehensive security protection mechanisms, and excellent reliability that addresses the stringent requirements for stable and long-term storage of critical configuration data. These offered features will benefit applications in industrial, energy, Internet-of-Things (IoT), data centers, and networking. As GigaDevice’s first EEPROM product series, the launch further enhances the company’s non-volatile memory portfolio and provides customers with more dynamic storage solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260702394554/en/ GigaDevice Launches First GD24CL Series I²C EEPROM, Further Expanding Its Non-Volatile Memory Portfolio. The GD24CL series is designed with high
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Spur® Peripheral Retrievable Scaffold System in a Select CLTI Cohort2.7.2026 13:00:00 CEST | Press release
Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported by a grant, investigates early vessel recoil following below-the-knee treatment using the Spur® Peripheral Retrievable Scaffold System in combination with a commercially available drug-coated balloon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701995624/en/ The study investigates early vessel recoil following below-the-knee treatment using the Spur® Peripheral Retrievable Scaffold System in combination with a commercially available drug-coated balloon. The study plans to enroll up to 40 patients with chronic limb-threatening ischemia (CLTI) across two distinct cohorts: patients with diabetes and patients with end-stage renal disease receiving hemodialysis for at least six months, with women comprisi
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)2.7.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to eight newly hired non-executive employees. The equity awards were granted on July 1, 2026 and consisted of options to purchase an aggregate of 63,685 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 30,300 shares. The options have an exercise price per share equal to $13.29, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted sh
Infobip Launches PitchMate — An AI Fan Companion for Global Football2.7.2026 12:00:00 CEST | Press release
Two AI agents. Two global sports. One platform redefining what it means to be a fan. Global AI-first cloud communications platform Infobip launched PitchMate, a new AI-powered conversational agent that brings football fans closer to the action of the world’s biggest football tournament. Purpose-built for the global football audience, PitchMate joins the TGR Haas F1 Team RaceMate — Infobip’s AI fan engagement solution for the TGR Haas F1 Team — in demonstrating how conversational AI is transforming fan engagement across sports worldwide. RaceMate, launched last April for this year’s motorsport season, is an AI agent on WhatsApp and Apple Messages for Business that puts TGR Haas F1 Team fans at the center of the action. It delivers real-time race data, personalized content, team radio highlights, trivia, and native multilingual support, turning passive viewers into active participants through natural, human-like conversations across every race weekend. Since its launch, RaceMate has reac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom